Menu
Back to User profile » Professor Ling-Chun Chen
Papers published by Professor Ling-Chun Chen:
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer
Cheng WJ, Lin SY, Chuang KH, Chen M, Ho HO, Chen LC, Hsieh CM, Sheu MT
International Journal of Nanomedicine 2022, 17:5353-5374
Published Date: 17 November 2022
Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas
Cheng WT, Ho HO, Lin SY, Liu DZ, Chen LC, Sheu MT
International Journal of Nanomedicine 2021, 16:6825-6841
Published Date: 5 October 2021
Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity
Cheng WJ, Lin SY, Chen M, Chen LC, Ho HO, Chuang KH, Sheu MT
International Journal of Nanomedicine 2021, 16:4017-4030
Published Date: 10 June 2021
Honokiol/Magnolol-Loaded Self-Assembling Lecithin-Based Mixed Polymeric Micelles (lbMPMs) for Improving Solubility to Enhance Oral Bioavailability
Lin HL, Cheng WT, Chen LC, Ho HO, Lin SY, Hsieh CM
International Journal of Nanomedicine 2021, 16:651-665
Published Date: 26 January 2021
TEMPO-Oxidized Sacchachitin Nanofibers (TOSCNFs) Combined with Platelet-Rich Plasma (PRP) for Management of Dry Eye Syndrome
Lin HL, Wu TH, Ho HO, Chao FC, Wu MH, Liu DZ, Chen LC, Sheu MT
International Journal of Nanomedicine 2020, 15:1721-1730
Published Date: 12 March 2020
Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
Cheng WJ, Chen LC, Ho HO, Lin HL, Sheu MT
International Journal of Nanomedicine 2018, 13:7079-7094
Published Date: 2 November 2018